RxDoctor Payments Data

Corey Teagarden

Obstetrics & Gynecology · Torrington, CTNPI 1043504756

Payments from drug & device makers

What this record shows

This record is dominated by education: $4,518 of the $6,436 with a category attached, or 70.2%. Intuitive Surgical accounts for 69.9% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $4,646 and has fallen 88.2% since, to $550 in 2025. Among obstetrics & gynecology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,436in general payments, 2019–2025

Across 84 payments — averaging $76.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • AbbVie$356
  • Mayne Pharma Commercial LLC$269
  • Aspira Women's Health Inc$169
  • Sumitomo Pharma America, Inc.$139
  • Exact Sciences$130
  • plus $873 from 16 others

What the payments were for

  • Food & beverage$1,91830%
  • Education$4,51870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,436 in reported general payments places this provider in the 95th percentile of 605 obstetrics & gynecology providers in Connecticut.

See all obstetrics & gynecology providers in Connecticut

Medicare billing

Part B allowed, 2024
$8,043
Medicare patients
55
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol21$1,653
Clobetasol Propionate19$1,117
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$219

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →